Towards the Equitable Distribution of COVID-19 Vaccines in Africa

Infections caused by the virus responsible for the COVID-19 pandemic have delivered a decisive blow to health systems across the world and resulted in drastic economic hardships. COVID-19 vaccines have proven to reduce the risk of mortality and morbidity against the virus responsible for the COVID-19 pandemic and hence the vaccine must be distributed equitably among the global community. The comparatively low rate of vaccination in many of the low and middle income African countries, risks prolonging the pandemic and the emergence of new and dangerous variants of COVID-19. The vaccine supply chain has been also chiefly directed towards high-income countries, while African countries continue to distribute the COVID-19

[1]  O. Watson,et al.  Global impact of the first year of COVID-19 vaccination: a mathematical modelling study , 2022, The Lancet Infectious Diseases.

[2]  R. Oehler,et al.  Conquering COVID: How Global Vaccine Inequality Risks Prolonging the Pandemic , 2021, Open forum infectious diseases.

[3]  U. V. Ukah,et al.  COVID-19 vaccine hesitancy in Africa: a scoping review , 2021, Global Health Research and Policy.

[4]  J. Nkengasong,et al.  COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead , 2021, Immunity.

[5]  G. Fink,et al.  Mobile nudges and financial incentives to improve coverage of timely neonatal vaccination in rural areas (GEVaP trial): A 3-armed cluster randomized controlled trial in Northern Ghana , 2021, PloS one.

[6]  Riccardo Pelizzo,et al.  How COVID-19 has Affected Africa’s Development , 2021, World Affairs.

[7]  M. Jit,et al.  Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment , 2021, The Lancet.

[8]  A. Verbeke Will the COVID‐19 Pandemic Really Change the Governance of Global Value Chains? , 2020, British Journal of Management.

[9]  Jayant Rajgopal,et al.  Optimizing vaccine distribution networks in low and middle-income countries , 2019, Omega.

[10]  K. O'Brien,et al.  Mobile phone-delivered reminders and incentives to improve childhood immunisation coverage and timeliness in Kenya (M-SIMU): a cluster randomised controlled trial , 2017, The Lancet. Global health.

[11]  Philip R. Johnson,et al.  Accelerating Next-Generation Vaccine Development for Global Disease Prevention , 2013, Science.

[12]  M. Hajer Policy without polity? Policy analysis and the institutional void , 2003 .